Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Liberti

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|May 16, 2025
The FDA's Pivotal Role in Global Therapeutic Product AvailabilityLawrence Liberti, Eunjoo Pacifici
Nature Reviews. Drug Discovery|January 6, 2018
Accelerated approval of medicines: fit for purpose?Alasdair Breckenridge, Lawrence Liberti
Pharmaceutical Medicine|February 4, 2021
The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested SolutionsMagdalena Bujar, Neil McAuslane, Lawrence Liberti
Clinical Pharmacology and Therapeutics|November 26, 2018
The Confluence of Accelerated Regulatory and Health Technology Assessment Access PathwaysNeil McAuslane, Lawrence Liberti, Patricia Connelly
Therapeutic Innovation & Regulatory Science|August 17, 2023
Direct-to-Consumer Genetic Testing: A Comprehensive ReviewSharon Jiang, Lawrence Liberti, David Lebo
Therapeutic Innovation & Regulatory Science|August 8, 2023
A Mixed Methods Study to Explore Relevant Metrics for a Results Framework Measuring the Public Health Impact of Reliance-Based PathwaysInez Adams, Patricia A Cuff, Lawrence Liberti
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Benefit-Risk Assessment of Medicines: Experience of a Consortium of Medium-Sized Regulatory AuthoritiesNeil McAuslane, James Leong, Lawrence Liberti, et al.
Clinical Therapeutics|July 7, 2022
Cooperation Agreements, Memorandums of Understanding, and Letters of Intent as Instruments to Facilitate the Implementation of Reliance in Latin AmericaHeraclio Rodríguez, María Lucia De Lucia, Lawrence Liberti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and ScotlandNicola Allen, Stuart R Walker, Lawrence Liberti, et al.
Frontiers in Pharmacology|July 18, 2017
A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?Nicola Allen, Lawrence Liberti, Stuart R Walker, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|May 16, 2025
The FDA's Pivotal Role in Global Therapeutic Product AvailabilityLawrence Liberti, Eunjoo Pacifici
Nature Reviews. Drug Discovery|January 6, 2018
Accelerated approval of medicines: fit for purpose?Alasdair Breckenridge, Lawrence Liberti
Pharmaceutical Medicine|February 4, 2021
The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested SolutionsMagdalena Bujar, Neil McAuslane, Lawrence Liberti
Clinical Pharmacology and Therapeutics|November 26, 2018
The Confluence of Accelerated Regulatory and Health Technology Assessment Access PathwaysNeil McAuslane, Lawrence Liberti, Patricia Connelly
Therapeutic Innovation & Regulatory Science|August 17, 2023
Direct-to-Consumer Genetic Testing: A Comprehensive ReviewSharon Jiang, Lawrence Liberti, David Lebo
Therapeutic Innovation & Regulatory Science|August 8, 2023
A Mixed Methods Study to Explore Relevant Metrics for a Results Framework Measuring the Public Health Impact of Reliance-Based PathwaysInez Adams, Patricia A Cuff, Lawrence Liberti
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Benefit-Risk Assessment of Medicines: Experience of a Consortium of Medium-Sized Regulatory AuthoritiesNeil McAuslane, James Leong, Lawrence Liberti, et al.
Clinical Therapeutics|July 7, 2022
Cooperation Agreements, Memorandums of Understanding, and Letters of Intent as Instruments to Facilitate the Implementation of Reliance in Latin AmericaHeraclio Rodríguez, María Lucia De Lucia, Lawrence Liberti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and ScotlandNicola Allen, Stuart R Walker, Lawrence Liberti, et al.
Frontiers in Pharmacology|July 18, 2017
A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?Nicola Allen, Lawrence Liberti, Stuart R Walker, et al.
Pageof 3